JULIE KOLIS: Open Payments
NPI 1528469749 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 27 payments from 8 companies in 2025. Trend: 2023 $574 · 2024 $238 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $139 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Novo Nordisk Inc | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Amgen Inc. | 1 | $13 |
Products named: ELIQUIS, LifeVest, JARDIANCE, LEQVIO, FARXIGA, Wegovy, NEXLETOL, REPATHA.
Industry payments across NC — which companies pay providers there.
